Cargando…

An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone

Background and objective Facial aesthetics have a huge impact on how individuals view themselves and are viewed by society. The aesthetics of the face are tremendously influenced by the shape of the chin and neck. In this study, we aimed to observe the outcomes in individuals after the use of ATX-10...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Husnain, Ul Ain, Nur, Bhatti, Dujanah S, Khan, Junaid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037223/
https://www.ncbi.nlm.nih.gov/pubmed/36968884
http://dx.doi.org/10.7759/cureus.35286
_version_ 1784911829964685312
author Khan, Husnain
Ul Ain, Nur
Bhatti, Dujanah S
Khan, Junaid
author_facet Khan, Husnain
Ul Ain, Nur
Bhatti, Dujanah S
Khan, Junaid
author_sort Khan, Husnain
collection PubMed
description Background and objective Facial aesthetics have a huge impact on how individuals view themselves and are viewed by society. The aesthetics of the face are tremendously influenced by the shape of the chin and neck. In this study, we aimed to observe the outcomes in individuals after the use of ATX-101 (deoxycholic acid injection) in an expanded safe zone for submental fullness. To ensure optimal outcomes and reduce the risk of adverse events, appropriate patient selection is the key. ATX-101 treatment may be administered in combination with hyaluronic acid fillers, botulinum toxins, cryolipolysis, and radiofrequency treatment. This is the first study of its kind to be carried out at the national level in Pakistan. Materials and methods This was a quasi-experimental study conducted at the Rawalian Burn and Reconstructive Surgery Unit, Holy Family Hospital, Rawalpindi, Pakistan for a period of nine months, from 10-1-2021 to 11-10-2021. A total of 62 patients who fulfilled the inclusion criteria were enrolled. We recorded if any complications had occurred or not. Moreover, the total number of treatment sessions, the volume of injectables used, and the interval between sessions were also documented. ATX-101 package was injected into the treatment area. Due care was taken to avoid the region of the marginal mandibular nerve. After the procedure, outcomes and complications were observed. Results In this study, patient satisfaction was reported in 59 (95.2%) patients. After the fourth session, final improvement was observed in 59 (95.16%) patients. Tenderness was found in seven (11.3%) patients, bruising was noted in four (6.5%), edema was found in seven (11.3%), numbness was noted in one (1.6%), whereas paresis and alopecia were not found in any of the patients. Conclusion Our study concluded that ATX-101 is a very useful modality with fewer complication rates and is associated with significant improvement in the expanded safe zone for submental fullness.
format Online
Article
Text
id pubmed-10037223
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-100372232023-03-25 An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone Khan, Husnain Ul Ain, Nur Bhatti, Dujanah S Khan, Junaid Cureus Dermatology Background and objective Facial aesthetics have a huge impact on how individuals view themselves and are viewed by society. The aesthetics of the face are tremendously influenced by the shape of the chin and neck. In this study, we aimed to observe the outcomes in individuals after the use of ATX-101 (deoxycholic acid injection) in an expanded safe zone for submental fullness. To ensure optimal outcomes and reduce the risk of adverse events, appropriate patient selection is the key. ATX-101 treatment may be administered in combination with hyaluronic acid fillers, botulinum toxins, cryolipolysis, and radiofrequency treatment. This is the first study of its kind to be carried out at the national level in Pakistan. Materials and methods This was a quasi-experimental study conducted at the Rawalian Burn and Reconstructive Surgery Unit, Holy Family Hospital, Rawalpindi, Pakistan for a period of nine months, from 10-1-2021 to 11-10-2021. A total of 62 patients who fulfilled the inclusion criteria were enrolled. We recorded if any complications had occurred or not. Moreover, the total number of treatment sessions, the volume of injectables used, and the interval between sessions were also documented. ATX-101 package was injected into the treatment area. Due care was taken to avoid the region of the marginal mandibular nerve. After the procedure, outcomes and complications were observed. Results In this study, patient satisfaction was reported in 59 (95.2%) patients. After the fourth session, final improvement was observed in 59 (95.16%) patients. Tenderness was found in seven (11.3%) patients, bruising was noted in four (6.5%), edema was found in seven (11.3%), numbness was noted in one (1.6%), whereas paresis and alopecia were not found in any of the patients. Conclusion Our study concluded that ATX-101 is a very useful modality with fewer complication rates and is associated with significant improvement in the expanded safe zone for submental fullness. Cureus 2023-02-22 /pmc/articles/PMC10037223/ /pubmed/36968884 http://dx.doi.org/10.7759/cureus.35286 Text en Copyright © 2023, Khan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Khan, Husnain
Ul Ain, Nur
Bhatti, Dujanah S
Khan, Junaid
An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
title An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
title_full An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
title_fullStr An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
title_full_unstemmed An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
title_short An Assessment of the Reduction of Submental Fullness With ATX-101 (Deoxycholic Acid Injection) in the Expanded Safe Zone
title_sort assessment of the reduction of submental fullness with atx-101 (deoxycholic acid injection) in the expanded safe zone
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037223/
https://www.ncbi.nlm.nih.gov/pubmed/36968884
http://dx.doi.org/10.7759/cureus.35286
work_keys_str_mv AT khanhusnain anassessmentofthereductionofsubmentalfullnesswithatx101deoxycholicacidinjectionintheexpandedsafezone
AT ulainnur anassessmentofthereductionofsubmentalfullnesswithatx101deoxycholicacidinjectionintheexpandedsafezone
AT bhattidujanahs anassessmentofthereductionofsubmentalfullnesswithatx101deoxycholicacidinjectionintheexpandedsafezone
AT khanjunaid anassessmentofthereductionofsubmentalfullnesswithatx101deoxycholicacidinjectionintheexpandedsafezone
AT khanhusnain assessmentofthereductionofsubmentalfullnesswithatx101deoxycholicacidinjectionintheexpandedsafezone
AT ulainnur assessmentofthereductionofsubmentalfullnesswithatx101deoxycholicacidinjectionintheexpandedsafezone
AT bhattidujanahs assessmentofthereductionofsubmentalfullnesswithatx101deoxycholicacidinjectionintheexpandedsafezone
AT khanjunaid assessmentofthereductionofsubmentalfullnesswithatx101deoxycholicacidinjectionintheexpandedsafezone